Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
19
KNW Quote, Financials, Valuation and Earnings
Last price:
$0.14
Seasonality move
:
24.87%
Day range:
$0.13 - $0.16
52-week range:
$0.13 - $0.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.4M
Avg. volume:
664.1K
1-year change:
-75.75%
Market cap:
$15.5M
Revenue:
--
EPS (TTM):
-$0.20
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $121.9K | -- | $4.4M | -- | -- | |
| Revenue Growth (YoY) | -93.24% | -- | -- | -- | -- | |
| Cost of Revenues | $69.7K | -- | $3.4M | -$274K | -- | |
| Gross Profit | $52.2K | -- | $929.7K | $274K | -- | |
| Gross Profit Margin | 42.82% | -- | 21.32% | -- | -- | |
| R&D Expenses | $2M | $4M | $5.4M | $7.7M | $6.1M | |
| Selling, General & Admin | $4.8M | $6.5M | $8.1M | $6.6M | $9.1M | |
| Other Inc / (Exp) | -$642K | -- | $521.6K | -$1M | -- | |
| Operating Expenses | $6.9M | $10.4M | $13.5M | $14.3M | $15.2M | |
| Operating Income | -$6.8M | -$10.4M | -$12.6M | -$14M | -$15.2M | |
| Net Interest Expenses | $6.1M | $14.9M | $8M | -- | -- | |
| EBT. Incl. Unusual Items | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Basic EPS (Cont. Ops) | -$0.62 | -$0.86 | -$0.50 | -$0.41 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -$0.62 | -$0.86 | -$0.50 | -$0.41 | -$0.20 | |
| Weighted Average Basic Share | $21.8M | $29.4M | $40.4M | $49.6M | $86.1M | |
| Weighted Average Diluted Share | $21.8M | $29.4M | $40.4M | $49.6M | $86.1M | |
| EBITDA | -$7.2M | -$10.2M | -$11.7M | -$14.4M | -$14.8M | |
| EBIT | -$7.5M | -$10.4M | -$12M | -$14.9M | -$15.1M | |
| Revenue (Reported) | $121.9K | -- | $4.4M | -- | -- | |
| Operating Income (Reported) | -$6.8M | -$10.4M | -$12.6M | -$14M | -$15.2M | |
| Operating Income (Adjusted) | -$7.5M | -$10.4M | -$12M | -$14.9M | -$15.1M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -$6.5K | -- | -- | |
| Gross Profit | -- | -- | $6.5K | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $720.2K | $875.9K | $2M | $1.5M | $1.1M | |
| Selling, General & Admin | $1.7M | $1.5M | $3.9M | $1.1M | $2.1M | |
| Other Inc / (Exp) | -$450 | -- | $259.7K | -$618.5K | -- | |
| Operating Expenses | $2.4M | $2.4M | $5.8M | $2.6M | $3.2M | |
| Operating Income | -$2.4M | -$2.4M | -$5.8M | -$2.3M | -$3.2M | |
| Net Interest Expenses | $1.9M | $5.2M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$4.3M | -$7.6M | -$5.6M | -$2.9M | -$3.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$4.3M | -$7.6M | -$5.6M | -$2.9M | -$3.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$4.3M | -$7.6M | -$5.6M | -$2.9M | -$3.6M | |
| Basic EPS (Cont. Ops) | -$0.18 | -$0.22 | -$0.13 | -$0.05 | -$0.04 | |
| Diluted EPS (Cont. Ops) | -$0.18 | -$0.22 | -$0.13 | -$0.05 | -$0.04 | |
| Weighted Average Basic Share | $24.6M | $34.5M | $44.4M | $52.5M | $97.3M | |
| Weighted Average Diluted Share | $24.6M | $34.5M | $44.4M | $52.5M | $97.3M | |
| EBITDA | -$2.3M | -$2.4M | -$5.2M | -$2.8M | -$3.1M | |
| EBIT | -$2.4M | -$2.4M | -$5.3M | -$2.9M | -$3.2M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$2.4M | -$2.4M | -$5.8M | -$2.3M | -$3.2M | |
| Operating Income (Adjusted) | -$2.4M | -$2.4M | -$5.3M | -$2.9M | -$3.2M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $3.4M | -- | -- | |
| Gross Profit | $52.2K | -- | $929.6K | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2M | $4M | $5.4M | $7.7M | $6.1M | |
| Selling, General & Admin | $4.8M | $6.5M | $8.1M | $6.6M | $9.1M | |
| Other Inc / (Exp) | -$642K | -- | $521.6K | -$950.2K | -- | |
| Operating Expenses | $6.9M | $10.4M | $13.5M | $14.3M | $15.2M | |
| Operating Income | -$6.8M | -$10.4M | -$12.6M | -$14M | -$15.2M | |
| Net Interest Expenses | $6.1M | $14.9M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Basic EPS (Cont. Ops) | -$0.62 | -$0.86 | -$0.51 | -$0.41 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -$0.62 | -$0.86 | -$0.51 | -$0.41 | -$0.20 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -$7.2M | -$10.2M | -$11.7M | -$14.5M | -$14.8M | |
| EBIT | -$7.5M | -$10.4M | -$12M | -$14.9M | -$15.1M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -$6.8M | -$10.4M | -$12.6M | -$14M | -$15.2M | |
| Operating Income (Adjusted) | -$7.5M | -$10.4M | -$12M | -$14.9M | -$15.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $4.4M | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $3.4M | -- | -- | -- | |
| Gross Profit | -- | $929.7K | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4M | $5.4M | $7.7M | $6.1M | -- | |
| Selling, General & Admin | $6.5M | $8.1M | $6.6M | $9.1M | -- | |
| Other Inc / (Exp) | -- | $521.6K | -$950.2K | -- | -- | |
| Operating Expenses | $10.4M | $13.5M | $14.3M | $15.2M | -- | |
| Operating Income | -$10.4M | -$12.6M | -$14M | -$15.2M | -- | |
| Net Interest Expenses | $14.9M | $7.8M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$25.4M | -$20.1M | -$15.3M | -$16.6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$25.4M | -$20.1M | -$15.3M | -$16.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$25.4M | -$20.1M | -$15.3M | -$16.6M | -- | |
| Basic EPS (Cont. Ops) | -$0.86 | -$0.51 | -$0.41 | -$0.20 | -- | |
| Diluted EPS (Cont. Ops) | -$0.86 | -$0.51 | -$0.41 | -$0.20 | -- | |
| Weighted Average Basic Share | $117.5M | $161.5M | $197.8M | $343.2M | -- | |
| Weighted Average Diluted Share | $117.5M | $161.5M | $197.8M | $343.2M | -- | |
| EBITDA | -$10.2M | -$11.7M | -$14.5M | -$14.8M | -- | |
| EBIT | -$10.4M | -$12M | -$14.9M | -$15.1M | -- | |
| Revenue (Reported) | -- | $4.4M | -- | -- | -- | |
| Operating Income (Reported) | -$10.4M | -$12.6M | -$14M | -$15.2M | -- | |
| Operating Income (Adjusted) | -$10.4M | -$12M | -$14.9M | -$15.1M | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Property Plant And Equipment | $257.7K | $617.5K | $1.2M | $226.4K | $404.5K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $101.1K | -- | -- | -- | -- | |
| Other Long-Term Assets | $25.2K | $13.8K | $13.8K | $15.8K | $149.2K | |
| Total Assets | $4.7M | $12.9M | $13.8M | $8.3M | $3.7M | |
| Accounts Payable | $493.5K | $419.1K | $527K | $1.3M | $552.7K | |
| Accrued Expenses | $992.8K | $1.3M | $811.2K | $312.4K | $186.2K | |
| Current Portion Of Long-Term Debt | $4M | $9.2M | $2.3M | $2.8M | $4.3M | |
| Current Portion Of Capital Lease Obligations | $108.8K | $112.4K | $215.4K | $154.8K | $108.6K | |
| Other Current Liabilities | $785K | -- | -- | -- | -- | |
| Total Current Liabilities | $6.3M | $11M | $3.8M | $4.5M | $5.2M | |
| Long-Term Debt | $226.2K | $431.8K | -- | -- | $407.5K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.6M | $11.6M | $3.9M | $4.5M | $5.8M | |
| Common Stock | $27.6K | $38K | $51K | $83.2K | $110.8K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -$1.9M | $1.2M | $9.9M | $3.7M | -$2.2M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.9M | $1.2M | $9.9M | $3.7M | -$2.2M | |
| Total Liabilities and Equity | $4.7M | $12.9M | $13.8M | $8.3M | $3.7M | |
| Cash and Short Terms | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Total Debt | $4.2M | $9.6M | $2.3M | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Property Plant And Equipment | $257.7K | $617.5K | $1.2M | $226.4K | $404.5K | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | $101.1K | -- | -- | -- | -- | |
| Other Long-Term Assets | $25.2K | $13.8K | $13.8K | $15.8K | $149.2K | |
| Total Assets | $4.7M | $12.9M | $13.8M | $8.3M | $3.7M | |
| Accounts Payable | $493.5K | $419.1K | $527K | $1.3M | $552.7K | |
| Accrued Expenses | $992.8K | $1.3M | $811.2K | $312.4K | $186.2K | |
| Current Portion Of Long-Term Debt | $4M | $9.2M | $2.3M | $2.8M | $4.3M | |
| Current Portion Of Capital Lease Obligations | $108.8K | $112.4K | $215.4K | $154.8K | $108.6K | |
| Other Current Liabilities | $785K | -- | -- | -- | -- | |
| Total Current Liabilities | $6.3M | $11M | $3.8M | $4.5M | $5.2M | |
| Long-Term Debt | $226.2K | $431.8K | -- | -- | $407.5K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $6.6M | $11.6M | $3.9M | $4.5M | $5.8M | |
| Common Stock | $27.6K | $38K | $51K | $83.2K | $110.8K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -$1.9M | $1.2M | $9.9M | $3.7M | -$2.2M | |
| Total Liabilities and Equity | $4.7M | $12.9M | $13.8M | $8.3M | $3.7M | |
| Cash and Short Terms | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Total Debt | $4.2M | $9.6M | -- | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Depreciation & Amoritzation | $243K | $200.8K | $357K | $455.9K | $270.2K | |
| Stock-Based Compensation | $1.7M | $1M | $4.4M | $3M | $3M | |
| Change in Accounts Receivable | $63.1K | -- | -- | -- | -- | |
| Change in Inventories | $7.1K | -- | -- | -- | -- | |
| Cash From Operations | -$3.9M | -$6.9M | -$6.9M | -$10.4M | -$12.8M | |
| Capital Expenditures | $70.1K | $299.5K | $855.5K | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$70.1K | -$299.5K | -$855.5K | -$80.8K | -$66.4K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.9M | $14.4M | -- | -- | $3.8M | |
| Long-Term Debt Repaid | -- | -- | -$179.1K | -- | -$982.5K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $305K | -$640.9K | -$855.3K | -- | -- | |
| Cash From Financing | $6.4M | $15.1M | $8.1M | $5.9M | $8M | |
| Beginning Cash (CF) | $1.9M | $4.3M | $12.3M | $12.6M | $8M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4M | $8M | $335.5K | -$4.6M | -$4.9M | |
| Ending Cash (CF) | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Levered Free Cash Flow | -$4M | -$7.2M | -$7.8M | -$10.4M | -$12.9M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$4.3M | -$7.6M | -$5.6M | -$2.9M | -$3.6M | |
| Depreciation & Amoritzation | $78.9K | $34.7K | $138.3K | $100.2K | $48.5K | |
| Stock-Based Compensation | $1M | -$1.7M | $2.9M | $491.9K | $626K | |
| Change in Accounts Receivable | -- | -- | $46.2K | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$1.2M | -$1.7M | -$3.2M | -$1.4M | -$3.3M | |
| Capital Expenditures | $57.1K | $252K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$57.1K | -$252K | -$11.9K | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -$41.6K | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -$720K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $785K | -$253.8K | -- | -- | -- | |
| Cash From Financing | $940.6K | $346.2K | $7.5M | $5.5M | $4.2M | |
| Beginning Cash (CF) | $4.7M | $13.9M | $8.4M | $3.9M | $2.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$364.2K | -$1.6M | $4.2M | $4.1M | $980.8K | |
| Ending Cash (CF) | $4.3M | $12.3M | $12.6M | $8M | $3.1M | |
| Levered Free Cash Flow | -$1.3M | -$2M | -$3.2M | -$1.4M | -$3.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$13.6M | -$25.4M | -$20.1M | -$15.3M | -$16.6M | |
| Depreciation & Amoritzation | $243K | $200.8K | $357K | $455.9K | $270.2K | |
| Stock-Based Compensation | $1.7M | $1M | $4.4M | $3M | $3M | |
| Change in Accounts Receivable | $63K | -- | -- | -- | -- | |
| Change in Inventories | $7.1K | -- | -- | -- | -- | |
| Cash From Operations | -$3.9M | -$6.9M | -$6.9M | -$10.4M | -$12.8M | |
| Capital Expenditures | $70.1K | $299.5K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$70.1K | -$299.5K | -$855.5K | -$80.8K | -$66.4K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5.9M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $305K | -$640.9K | -- | -- | -- | |
| Cash From Financing | $6.4M | $15.1M | $8.1M | $5.9M | $8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.4M | $8M | $335.5K | -$4.6M | -$4.9M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$4M | -$7.2M | -$7.8M | -$10.4M | -$12.9M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$25.4M | -$20.1M | -$15.3M | -$16.6M | -- | |
| Depreciation & Amoritzation | $200.8K | $357K | $455.9K | $270.2K | -- | |
| Stock-Based Compensation | $1M | $4.4M | $3M | $3M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6.9M | -$6.9M | -$10.4M | -$12.8M | -- | |
| Capital Expenditures | $299.5K | $827K | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$299.5K | -$855.5K | -$80.8K | -$66.4K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $14.4M | -- | -- | $3.8M | -- | |
| Long-Term Debt Repaid | -- | -$179.1K | -- | -$982.5K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$640.9K | -- | -- | -- | -- | |
| Cash From Financing | $15.1M | $8.1M | $5.9M | $8M | -- | |
| Beginning Cash (CF) | $36.8M | $42.5M | $32.4M | $19.7M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $8M | $335.5K | -$4.6M | -$4.9M | -- | |
| Ending Cash (CF) | $44.8M | $42.9M | $27.9M | $14.8M | -- | |
| Levered Free Cash Flow | -$7.2M | -$7.8M | -$10.4M | -$12.9M | -- | |
Get KNW Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KNW
Sector
P/E ratio
--
25.86x
PEG ratio
-0.03x
0.00x
P/B ratio
--
1.85x
Price / LTM sales
--
1.86x
Growth Metrics
KNW
Sector
Revenue growth
--
7.28%
Earnings growth
--
1.82%
Revenue (5-year growth)
--
8.73%
Earnings forecast
-$0.05
-$0.20
Profitability
KNW
Sector
Profitability FY 2024
--
$57.1M
Return on invested capital
--
-14.06%
Return on assets
--
-11.77%
Return on equity
--
-14.78%
Earnings Date
Last Earnings Date
Nov
15
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Feb
14
Balance Sheet
KNW
Sector
Total cash
$3.1M
$47M
Short term investments
--
$45.2M
Total assets
$3.7M
$142.6M
Long term debt
--
$6.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
